Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  9, 416 - 423 (2003)
Published online: 17 March 2003; | doi:10.1038/nm843

Predicting hepatitis B virus−positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

Qing-Hai Ye1, Lun-Xiu Qin1, Marshonna Forgues2, Ping He2, Jin Woo Kim2, Amy C. Peng3, 4, Richard Simon3, Yan Li1, Ana I. Robles2, Yidong Chen5, Zeng-Chen Ma1, Zhi-Quan Wu1, Sheng-Long Ye1, Yin-Kun Liu1, Zhao-You Tang1 & Xin Wei Wang2

1  Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China

2  Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA

3  Biometrics Research Branch, National Cancer Institute, Rockville, Maryland, USA

4  EMMES Corp., Rockville, Maryland, USA

5  Laboratory of Cancer Genetics, National Human Genome Research Institute, Bethesda, Maryland, USA

Correspondence should be addressed to Xin Wei Wang xw3u@nih.gov
Hepatocellular carcinoma (HCC) is one of the most common and aggressive human malignancies. Its high mortality rate is mainly a result of intra-hepatic metastases. We analyzed the expression profiles of HCC samples without or with intra-hepatic metastases. Using a supervised machine-learning algorithm, we generated for the first time a molecular signature that can classify metastatic HCC patients and identified genes that were relevant to metastasis and patient survival. We found that the gene expression signature of primary HCCs with accompanying metastasis was very similar to that of their corresponding metastases, implying that genes favoring metastasis progression were initiated in the primary tumors. Osteopontin, which was identified as a lead gene in the signature, was over-expressed in metastatic HCC; an osteopontin-specific antibody effectively blocked HCC cell invasion in vitro and inhibited pulmonary metastasis of HCC cells in nude mice. Thus, osteopontin acts as both a diagnostic marker and a potential therapeutic target for metastatic HCC.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

RESEARCH
A molecular signature of metastasis in primary solid tumors
Nature Genetics Letters (01 Jan 2003)
Prediction of central nervous system embryonal tumour outcome based on gene expression
Nature Letters to Editor (24 Jan 2002)
Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma
Oncogene Original Article (25 Jul 2002)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

naturejobs

Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy